KROS Competitors & Alternatives
Compare Keros Therapeutics Inc with similar stocks in the same industry
Biotechnology
KROS
Main Stock$10.06
Tradestie Score
48
Market Cap
$620.60M
Revenue Growth
-1.0%
Analyst Upside
+117.0%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NGNE
Neurogene, Inc. Common Stock
|
$32.93
|
$256.54M | - | 55 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$10.77
|
$240.89M | - | 55 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$10.94
|
$211.22M | - | 47 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$5.30
|
$202.58M | - | 60 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$14.80
|
$199.71M | - | 46 | Compare |
|
ASMB
Assembly Biosciences, Inc
|
$24.98
|
$188.81M | 325.8 | 47 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.68
|
$180.53M | - | 53 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$18.07
|
$170.45M | - | 57 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.35
|
$158.43M | - | 48 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$22.16
|
$154.27M | - | 61 | Compare |
More KROS Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry